{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:26:56Z","timestamp":1794637616622,"version":"4.9.1"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":635,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,3,29]]},"abstract":"<jats:p>There is little information available regarding immunophenotypic monitoring of minimal residual disease (MRD) in acute myeloid leukaemia (AML). We investigated leukaemic cells co\u2010expressing CD15 and CD117 (CD15+CD117+) in 72 adult AML cases at diagnosis. In 22 cases (31%) with various AML subtypes, more than 5% of leukaemic cells showed the CD15+CD117+ phenotype (range 5.22\u201355.48%). These 22 cases were younger and had a higher complete remission (CR) rate than the other AML cases, but the CD15+CD117+ cell percentage at diagnosis showed no correlation with the CR duration among the 72 cases. The CD15+CD117+ cell percentage showed a range of 0.00\u20130.08% in bone marrow cells from 10 haematologically normal subjects. We also investigated CD15+CD117+ cells in sequential bone marrow samples from 17 AML patients who achieved CR and who had had more than 5% CD15+CD117+ leukaemic cells at diagnosis. Because the CD15+CD117+ cell percentage varied among these AML cases, we calculated the percentage of MRD {MRD%\u2003=\u2003[CD15+CD117+ cells (%) in each sequential marrow sample]\u2003\u00f7\u2003[CD15+CD117+ cells (%) at diagnosis of the corresponding case]\u2003\u00d7\u2003100}. A high MRD% after 10 months of CR was significantly associated with a short CR duration (<jats:italic>P<\/jats:italic>\u2003=\u20030.0004), whereas continuation of a well\u2010reduced MRD% was associated with a long CR duration. The leukaemic cells conserved the CD15+CD117+ phenotype in all of the eight cases who relapsed. Flow cytometric monitoring of CD15+CD117+ cells is simple and can be applied to a substantial fraction of AML cases. This monitoring may be useful for predicting relapse of adult AML.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01906.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:23:03Z","timestamp":1047363783000},"page":"710-716","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Flow cytometric assessment of CD15+CD117+ cells for the detection of minimal residual disease in adult acute myeloid leukaemia"],"prefix":"10.1111","volume":"108","author":[{"given":"Kyoko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoyuki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"404","article-title":"Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease","volume":"4","author":"Adriaansen H.J.","year":"1990","journal-title":"Leukemia"},{"key":"e_1_2_5_3_1","first-page":"472","article-title":"Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers","volume":"7","author":"Adriaansen H.J.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.1.30.30"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-620"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1416.bloodjournal8561416"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.1.163.163"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/88.1.38"},{"key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood.V79.3.554.554","article-title":"The t (15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction","volume":"79","author":"Chang K.S.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.5.813"},{"key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1999.01365.x","article-title":"Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukemia by molecular analysis","volume":"105","author":"Foroni L.","year":"1999","journal-title":"British Journal of Haematology"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(80)90043-0"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.4.1264.1264"},{"key":"e_1_2_5_14_1","first-page":"403","article-title":"Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome","volume":"2","author":"Keating M.J.","year":"1988","journal-title":"Leukemia"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050054"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03309.x"},{"key":"e_1_2_5_17_1","first-page":"1896","article-title":"Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease","volume":"9","author":"Macedo A.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.6.1689.1689"},{"key":"e_1_2_5_19_1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V82.3.712.712","article-title":"Persistence of the 8; 21 translocation in patients with acute myeloid leukemia type M2 in long\u2010term remission","volume":"82","author":"Nucifora G.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04787.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V64.1.275.275","article-title":"Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies","volume":"64","author":"Pessano S.","year":"1984","journal-title":"Blood"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.11.3083.3083"},{"key":"e_1_2_5_23_1","first-page":"201","article-title":"The chromosomes in human leukemia","volume":"23","author":"Sandberg A.A.","year":"1986","journal-title":"Seminars in Hematology"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb02211.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2465"},{"key":"e_1_2_5_26_1","doi-asserted-by":"crossref","unstructured":"Stewart C.C.&Stewart S.J.(1994) Multiparameter analysis of leukocytes by flow cytometry.Methods in Cell Biology Vol. 41 (ed. by Z. Darzynkiewicz J.P. Robinson & H.A. Crissman) pp.6179. Academic Press San Diego.","DOI":"10.1016\/S0091-679X(08)61709-4"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0925-5710(97)00050-9"},{"key":"e_1_2_5_28_1","first-page":"70","article-title":"Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis","volume":"6","author":"Terstappen L.W.","year":"1992","journal-title":"Leukemia"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01906.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01906.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01906.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:04:15Z","timestamp":1698563055000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01906.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,29]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,3,29]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01906.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01906.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,29]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}